Mika Scheinin

Turku, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Safety, tolerability and immunogenicity of vaccine ALZ-101 in patients with early Alzheimer's disease: randomised, controlled trial.

Safety, tolerability and immunogenicity of vaccine ALZ-101 in patients with early Alzheimer's disease: randomised, controlled trial.

Journal: Alzheimer's research & therapy

Published: January 13, 2026

Stability of oxycodone solutions containing S-ketamine or dexmedetomidine.

Stability of oxycodone solutions containing S-ketamine or dexmedetomidine.

Journal: European journal of hospital pharmacy : science and practice

Published: December 17, 2025

Safety and Immunogenicity of a Vaccine Against Coxsackieviruses B (PRV-101)-Follow-up of the First-in-Human Phase 1 Trial.

Safety and Immunogenicity of a Vaccine Against Coxsackieviruses B (PRV-101)-Follow-up of the First-in-Human Phase 1 Trial.

Journal: Open forum infectious diseases

Published: June 03, 2025

Vasomotion in Human Fingers.

Vasomotion in Human Fingers.

Journal: Journal of vascular research

Published: March 31, 2025

Combined Immediate-Release and Extended-Release Formulation of Sodium Valproate Provides Stable Plasma Levels for Inhibition of Histone Deacetylation.

Combined Immediate-Release and Extended-Release Formulation of Sodium Valproate Provides Stable Plasma Levels for Inhibition of Histone Deacetylation.

Journal: Clinical pharmacology in drug development

Published: March 13, 2025

Effects of Dietary Restriction on Regulation of Energy Metabolism in Male Wistar Rats (Rattus norvegicus).

Effects of Dietary Restriction on Regulation of Energy Metabolism in Male Wistar Rats (Rattus norvegicus).

Journal: Journal of the American Association for Laboratory Animal Science : JAALAS

Published: November 20, 2024

Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial.

Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial.

Journal: Diabetologia

Published: September 18, 2023

Response to Letter to the Editor.

Response to Letter to the Editor.

Journal: Neurogastroenterology and motility

Published: May 05, 2023

Decreased Thalamic Activity Is a Correlate for Disconnectedness during Anesthesia with Propofol, Dexmedetomidine and Sevoflurane But Not S-Ketamine.

Decreased Thalamic Activity Is a Correlate for Disconnectedness during Anesthesia with Propofol, Dexmedetomidine and Sevoflurane But Not S-Ketamine.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: December 24, 2022

Effects of dexmedetomidine on pharyngeal swallowing and esophageal motility-A double-blind randomized cross-over study in healthy volunteers.

Effects of dexmedetomidine on pharyngeal swallowing and esophageal motility-A double-blind randomized cross-over study in healthy volunteers.

Journal: Neurogastroenterology and motility

Published: July 08, 2022

Uptake of 18F-rhPSMA-7.3 in Positron Emission Tomography Imaging of Prostate Cancer: A Phase 1 Proof-of-Concept Study.

Uptake of 18F-rhPSMA-7.3 in Positron Emission Tomography Imaging of Prostate Cancer: A Phase 1 Proof-of-Concept Study.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: December 28, 2021

Clinical trial site identification practices and the use of electronic health records in feasibility evaluations: An interview study in the Nordic countries.

Clinical trial site identification practices and the use of electronic health records in feasibility evaluations: An interview study in the Nordic countries.

Journal: Clinical trials (London, England)

Published: August 25, 2021

Showing 1-12 of 102

Last Updated: 09/26/2026